Read-Gene Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15.57	13.23	10.15	7.24	6.45
Revenue Growth (YoY)	17.67%	30.38%	40.14%	12.20%	6.34%
Cost of Revenue	1	0.89	1.02	1.06	0.7
Gross Profit	14.57	12.34	9.12	6.18	5.75
Selling, General & Admin	12.96	12.19	9.71	5.37	5.3
Other Operating Expenses	0.11	0.06	0.2	0.08	-0.23
Operating Expenses	13.52	12.73	10.4	5.9	5.64
Operating Income	1.04	-0.39	-1.27	0.29	0.11
Interest Expense	-0.33	-0.33	-0.4	-0.23	-0.06
Interest & Investment Income	0	-	0	0	0
Other Non Operating Income (Expenses)	-0	-0.01	-0	-0	-0
EBT Excluding Unusual Items	0.71	-0.73	-1.67	0.06	0.05
Gain (Loss) on Sale of Investments	-	0.15	0.05	-	-
Gain (Loss) on Sale of Assets	0.1	-	0	-	-
Pretax Income	0.81	-0.58	-1.62	0.06	0.05
Income Tax Expense	-	0.53	-0.28	-0.15	0.01
Net Income	0.81	-1.11	-1.35	0.21	0.04
Net Income to Common	0.81	-1.11	-1.35	0.21	0.04
Net Income Growth	-	-	-	462.78%	-89.15%
Shares Outstanding (Basic)	12	12	12	12	12
Shares Outstanding (Diluted)	12	12	12	12	12
EPS (Basic)	0.07	-0.09	-0.11	0.02	0.00
EPS (Diluted)	0.07	-0.09	-0.11	0.02	0.00
EPS Growth	-	-	-	462.87%	-89.15%
Free Cash Flow	-0.13	1.75	-1.18	0.33	0.05
Free Cash Flow Per Share	-0.01	0.15	-0.10	0.03	0.00
Gross Margin	93.56%	93.27%	89.91%	85.41%	89.09%
Operating Margin	6.70%	-2.95%	-12.54%	3.95%	1.76%
Profit Margin	5.19%	-8.40%	-13.27%	2.94%	0.59%
Free Cash Flow Margin	-0.82%	13.25%	-11.65%	4.61%	0.71%
EBITDA	1.49	0.09	-0.78	0.74	0.67
EBITDA Margin	9.59%	0.69%	-7.68%	10.25%	10.44%
D&A For EBITDA	0.45	0.48	0.49	0.46	0.56
EBIT	1.04	-0.39	-1.27	0.29	0.11
EBIT Margin	6.70%	-2.95%	-12.54%	3.95%	1.76%
Effective Tax Rate	-	-	-	-	27.93%
Revenue as Reported	15.57	13.23	10.15	7.24	6.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.